Biocon gets USFDA EIR with VAI Classification for its Malaysian Insulin Manufacturing Facility Medical Dialogues Bureau1 April 2020 7:14 AM GMTBengaluru: Biocon Sdn Bhd, a subsidiary of Biocon Limited has announced that it has received the Establishment Inspection Report (EIR) from the U.S. FD...
Novo Nordisk Tresiba shows lower risk of hypo in adults with Type 2 Diabetes Medical Dialogues Bureau21 Sep 2019 4:00 AM GMT'We are delighted that the findings of the CONCLUDE trial support what we have seen previously across the Tresiba clinical development programme,' said...
Biocon, Mylan get European Commission approval to market biosimilar insulin glargine Ruby Khatun Khatun30 March 2018 5:00 AM GMTNew Delhi: Biotechnology major Biocon and Mylan said their co-developed biosimilar insulin glargine has received marketing authorization approval from ...
